- Home
- News
- Topics
- FDA Week
- Inside CMS
- Inside Drug Pricing
- Health Exchange Alert
- Inside TeleHealth
- About Us
October 4, 2002 Contact: CDC Media Relations 404-639-3286
E.coli O157:H7 Outbreak Investigations
O157:H7 infections.
FOR IMMEDIATE RELEASE:
Monday, October 7 , 2002
CONTACT: Ken Johnson or Arturo Silva
202.225.5735
Greenwood Announces Hearing
On The ImClone Erbitux Story
WASHINGTON (October 7) -- House Energy and Commerce Oversight and Investigations Subcommittee Chairman James Greenwood (R-PA) has scheduled a hearing for Thursday (October 10 at 10:00 a.m. in room 2123 of the Rayburn House Office Building) entitled, "An Inquiry into the ImClone Cancer-Drug Story."
In a Sept. 25 letter to the Senate Finance Committee leader, CMS Administrator Tom Scully is requesting action on the administration's top legislative priorities: contractor reform, competitive bidding for durable medical equipment, and Medicare benefit improvements. Scully advises, however, that many provisions in the Senate's original regulatory reform bill, which was introduced last year, could be counterproductive as CMS has already implemented such changes.
Subject: HHS Regulatory Reform Committee Final Meeting -- 11/21/02
Please be advised that the final meeting of the Department of Health and Human Services (HHS) Secretary's Advisory Committee on Regulatory Reform which had originally been scheduled for October 1-2, 2002 has been rescheduled as follows:
Times: 8:00 am - 6:00 pm
Location: Washington, DC
The exact location and agenda for the meeting will be posted on the Regulatory Reform web-site at www.regreform.hhs.gov before the meeting.